Neuland Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 2,578.48 million compared to INR 2,413.93 million a year ago. Revenue was INR 2,581.34 million compared to INR 2,419.99 million a year ago. Net income was INR 203.71 million compared to INR 214.4 million a year ago. Basic earnings per share from continuing operations was INR 15.88 compared to INR 16.71 a year ago. Diluted earnings per share from continuing operations was INR 15.88 compared to INR 16.71 a year ago. For the six months, sales was INR 4,587.34 million compared to INR 4,468.17 million a year ago. Revenue was INR 4,610.77 million compared to INR 4,481.2 million a year ago. Net income was INR 291.06 million compared to INR 366.03 million a year ago. Basic earnings per share from continuing operations was INR 22.69 compared to INR 28.53 a year ago. Diluted earnings per share from continuing operations was INR 22.69 compared to INR 28.53 a year ago.